As shown in Figures 1(a) and 1(b), nasal immunization with bivalent flagellin protected against lethal pneumonia due to PAK (100% survival) and PAO1 (91.66% survival) and survival rates were all significantly higher than those in mice administered with PBS (P > 0.01). This evidence concerns the gene SMOX and pneumonia.